Witte MM[au] - Search Results

Year	Number of Results
1984	1
1987	1
1988	1
1990	1
1992	1
1993	1
1995	1
1996	1
1997	1
1999	1
2002	2
2006	1
2007	2
2009	2
2010	2
2011	5
2012	3
2013	1
2014	2
2015	4
2016	2
2018	1
2022	1

1

Regulation of differentiation, proliferation and cancer suppressor activity.

Scott RE, Tzen CY, Witte MM, Blatti S, Wang H. Scott RE, et al. Among authors: witte mm. Int J Dev Biol. 1993 Mar;37(1):67-74. Int J Dev Biol. 1993. PMID: 7685184 Free article. Review.

2

Florbetapir positron emission tomography and cerebrospinal fluid biomarkers.

Hake A, Trzepacz PT, Wang S, Yu P, Case M, Hochstetler H, Witte MM, Degenhardt EK, Dean RA; Alzheimer's Disease Neuroimaging Initiative. Hake A, et al. Among authors: witte mm. Alzheimers Dement. 2015 Aug;11(8):986-93. doi: 10.1016/j.jalz.2015.03.002. Epub 2015 Apr 24. Alzheimers Dement. 2015. PMID: 25916563 Free PMC article.

3

Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease.

Trzepacz PT, Hochstetler H, Yu P, Castelluccio P, Witte MM, Dell'Agnello G, Degenhardt EK; Alzheimer''s Disease Neuroimaging Initiative. Trzepacz PT, et al. Among authors: witte mm. Dement Geriatr Cogn Disord. 2016;41(1-2):68-79. doi: 10.1159/000441351. Epub 2015 Dec 2. Dement Geriatr Cogn Disord. 2016. PMID: 26625159

4

Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations.

Witte MM, Foster NL, Fleisher AS, Williams MM, Quaid K, Wasserman M, Hunt G, Roberts JS, Rabinovici GD, Levenson JL, Hake AM, Hunter CA, Van Campen LE, Pontecorvo MJ, Hochstetler HM, Tabas LB, Trzepacz PT. Witte MM, et al. Alzheimers Dement (Amst). 2015 Jul 26;1(3):358-67. doi: 10.1016/j.dadm.2015.06.006. eCollection 2015 Sep. Alzheimers Dement (Amst). 2015. PMID: 27239516 Free PMC article.

5

Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia.

Degenhardt EK, Witte MM, Case MG, Yu P, Henley DB, Hochstetler HM, D'Souza DN, Trzepacz PT. Degenhardt EK, et al. Among authors: witte mm. Psychosomatics. 2016 Mar-Apr;57(2):208-16. doi: 10.1016/j.psym.2015.12.002. Epub 2015 Dec 3. Psychosomatics. 2016. PMID: 26892326 Free article.

6

Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer's disease in an administrative claims database.

Nair R, Haynes VS, Siadaty M, Patel NC, Fleisher AS, Van Amerongen D, Witte MM, Downing AM, Fernandez LAH, Saundankar V, Ball DE. Nair R, et al. Among authors: witte mm. BMC Geriatr. 2018 Oct 16;18(1):243. doi: 10.1186/s12877-018-0920-2. BMC Geriatr. 2018. PMID: 30326851 Free PMC article.

7

Association between clinical measures and florbetapir F18 PET neuroimaging in mild or moderate Alzheimer's disease dementia.

Witte MM, Trzepacz P, Case M, Yu P, Hochstetler H, Quinlivan M, Sundell K, Henley D. Witte MM, et al. J Neuropsychiatry Clin Neurosci. 2014 Summer;26(3):214-20. doi: 10.1176/appi.neuropsych.12120402. J Neuropsychiatry Clin Neurosci. 2014. PMID: 24618911

8

Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.

Trzepacz PT, Yu P, Sun J, Schuh K, Case M, Witte MM, Hochstetler H, Hake A; Alzheimer's Disease Neuroimaging Initiative. Trzepacz PT, et al. Among authors: witte mm. Neurobiol Aging. 2014 Jan;35(1):143-51. doi: 10.1016/j.neurobiolaging.2013.06.018. Epub 2013 Aug 15. Neurobiol Aging. 2014. PMID: 23954175

9

Characteristics and outcome of children with renal tumors in the Netherlands: The first five-year's experience of national centralization.

Roy P, van Peer SE, de Witte MM, Tytgat GAM, Karim-Kos HE, van Grotel M, van de Ven CP, Mavinkurve-Groothuis AMC, Merks JHM, Kuiper RP, Hol JA, Janssens GOR, de Krijger RR, Jongmans MCJ, Drost J, van der Steeg AFW, Littooij AS, Wijnen MHWA, van Tinteren H, van den Heuvel-Eibrink MM. Roy P, et al. Among authors: de witte mm. PLoS One. 2022 Jan 13;17(1):e0261729. doi: 10.1371/journal.pone.0261729. eCollection 2022. PLoS One. 2022. PMID: 35025887 Free PMC article.

10

Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia.

Fijal BA, Kinon BJ, Kapur S, Stauffer VL, Conley RR, Jamal HH, Kane JM, Witte MM, Houston JP. Fijal BA, et al. Among authors: witte mm. Pharmacogenomics J. 2009 Oct;9(5):311-8. doi: 10.1038/tpj.2009.24. Epub 2009 May 19. Pharmacogenomics J. 2009. PMID: 19451915 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results